GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Chemical Biological and Genomic Approaches to Bacterial Virulence Regulation

$433,694
Deborah T Hung · Massachusetts General Hospital · R01 · FY2012 · AI

Quinolone and multidrug resistance in Staphylococcus aureus

$433,694
David C Hooper · Massachusetts General Hospital · R37 · FY2011 · AI

Chemical Biological and Genomic Approaches to Bacterial Virulence Regulation

$433,694
Deborah T Hung · Massachusetts General Hospital · R01 · FY2011 · AI

The Discovery of New Antibiotics from Deep Sea Actinomycete Bacteria

$433,651
William Fenical · University Of California, San Diego · R01 · FY2008 · GM

Determining the mechanism of inhibition of metallo-b-lactamase inhibitors

$433,500
Michael W Crowder · Miami University Oxford · R15 · FY2019 · GM

HOST GENETIC VARIATION REGULATING SALMONELLA INVASION AND DISEASE SUSCEPTIBILITY

$433,415
Dennis Chun-Yone Ko · Duke University · R01 · FY2017 · AI

The Abeta protein of Alzheimer's Disease is an antimicrobial peptide

$433,260
Robert D Moir · Massachusetts General Hospital · R01 · FY2010 · AI

Molecular Basis of Host Parasite Interaction

$433,157
Denise M. Monack · Stanford University · T32 · FY2020 · AI

Imaging Amphotericin B's Mechanism of Action with Transient Absorption Microscopy

$433,142
Tessa Rae Calhoun · University Of Tennessee Knoxville · R15 · FY2016 · GM

Network for Antimicrobial Resistance in Staphylococcus aureus

$433,105
Eurofins Medinet · N01 · FY2008 · AI

Task C08: Manufacturing of formulation platform of metronidazole for treating for treating Clostridium difficile infection

$432,944
Jon Mirsalis · Sri International · N01 · FY2023 · AI

Cell-mediated protection against pneumonic plague

$432,754
Stephen T Smiley · Trudeau Institute, Inc. · R01 · FY2009 · AI

Engineering “Phagebody” Antimicrobials for Carbapenem-Resistant Enterobacteriaceae

$432,695
Timothy Lu · Massachusetts Institute Of Technology · R33 · FY2018 · AI

Precision coordination of therapeutic and prophylactic antibiotics to reduce infection, toxicity, and emergence of resistance following acute abdominal surgery

$432,590
Manjunath P Pai · University Of Michigan At Ann Arbor · R01 · FY2025 · HS

Development of clinical decision tools for management of diarrhea of children in high and low resource settings

$432,549
Daniel Ted Leung · University Of Utah · R01 · FY2019 · AI

Protection Against Nosocomial Infections After Severe Burn Injury Through Trained Immunity

$432,500
Julia K. Bohannon · Vanderbilt University Medical Center · R35 · FY2023 · GM

Protection Against Nosocomial Infections After Severe Burn Injury Through Trained Immunity

$432,500
Julia K. Bohannon · Vanderbilt University Medical Center · R35 · FY2022 · GM

Protection Against Nosocomial Infections After Severe Burn Injury Through Trained Immunity

$432,500
Julia K. Bohannon · Vanderbilt University Medical Center · R35 · FY2025 · GM

Protection Against Nosocomial Infections After Severe Burn Injury Through Trained Immunity

$432,500
Julia K. Bohannon · Vanderbilt University Medical Center · R35 · FY2024 · GM

Enhancing Collectin Mediated Defense Against Influenza

$432,425
Kevan L Hartshorn · Boston Medical Center · R01 · FY2017 · HL

Enhancing Collectin Mediated Defense Against Influenza

$432,425
Kevan L Hartshorn · Boston Medical Center · R01 · FY2016 · HL

Oligosaccharides to Prevent Infectious Diarrhea

$432,394
John Michael McCoy · Glycosyn, Llc · R44 · FY2011 · AI

Molecular determinants of oxidative stress in Salmonella pathogenesis

$432,090
Andres Vazquez-Torres · University Of Colorado Denver · R01 · FY2019 · AI

In Vivo Gene Expression in Staphyloccus Aureus

$432,084
Ambrose L. Cheung · Dartmouth College · R01 · FY2009 · AI

Multi-omics Strategies to Improve Clinical Outcomes in Uveitis

$432,027
Jessica Shantha · University Of California, San Francisco · R01 · FY2025 · EY